HEALTHCARE (XLV)
$128.56
0.18 (0.14%)
XLV Stock Quote Delayed 30 Minutes
What Are the Best Sectors to Invest in for 2018?
The Energy, Consumer Discretionary and Technology sectors have been among the best sectors in terms of performance so far in 2018, and they are expected to continue this success for the remainder of the year.
11 Best Stocks to Buy for 2023
INSIDE: Investing legend Louis Navellier reveals his Top 11 Stocks for 2023 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
378.69M
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
16.04M
Day's Range
$127.06 - $128.60
52-Week Range
$119.95 - $141.77
Dividend & Yield
N/A (N/A)
XLV Stock Predictions, Articles, and HEALTHCARE News
The Analysts Are Right About Teladoc Inc — It’s a Buy!
While the healthcare sector is down, TDOC is up -- and for good reason. Teladoc and similar services are the future of healthcare.
Are Investors Out of the Woods After the Recent Pullback?
February’s pullback seems to have broken the bullish spell that had enveloped Wall Street, and now investors have to start doing their homework again.
Trade of the Day: UnitedHealth Group Is Waving Down the Bulls
So far in January, UnitedHealth stock has lagged the healthcare rally but UNH looks increasingly giddy for a breakout.
Respect the Choppy Stock Market
Volatility remains eerily low, but as a former mentor used to remind me, one can learn much by just watching and being prepared.
Volatility Rise Is on the Horizon
Despite last week's month-end rally in stocks, the seasonal increase in volatility in early fall remains a real risk for traders and investors.
Buy Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Before Q2 Earnings
Teva Pharmaceutical is shedding assets and beginning to get synergies from its M&A. TEVA stock looks like a compelling trade.
Health Care SPDR (ETF) (XLV): The Quick Guide to XLV
The Health Care Select Sector SPDR Fund (XLV) is the largest ETF focused on healthcare stocks, but is it the best one? We explore the XLV.
Trade of the Day: Health Care SPDR (ETF) (NYSEARCA:XLV)
Health care stocks have been lagging the S&P 500 lately, so I’m anticipating a rebound eventually.
Trade of the Day: Watch MDT Stock for a Breakout
Medtronic PLC is in a consolidation phase that looks ready to resolve to the upside.
Why Johnson & Johnson Is a Top Dow Pick (JNJ)
A study of analyst recommendations shows that Johnson & Johnson is the #17 broker pick, on average, out of the 30 stocks making up the Dow
4 Healthcare Stocks on Shaky Ground – MRK LLY AZN BMY
Biotechnology stocks have broken down, and certain pharmaceutical stocks are now following suit. Could Merck and other pharmas suffer more downside?
The Proper Context of Hedge Fund Money
Wall Street's rich and famous are having their worst yearly performance since 2011. Avoid big bets on hedge fund moves in your portfolio
Be Careful Before Loving Leveraged Biotech ETFs
The new crop of triple-leveraged biotech ETFs have had staggering returns (and losses), serving as a reminder that not all investors should be involved with leveraged ETFs.
